Related Experiment Video
Updated: Jul 10, 2026

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
Published on: December 19, 2020
Synthesis and immunochemical studies on a Candida albicans cluster glycoconjugate vaccine
Xiangyang Wu1, Tomasz Lipinski, Frédéric R Carrel
1Alberta Ingenuity Centre for Carbohydrate science, Department of Chemistry, University of Alberta, Edmonton, AB T6G 2G2, Canada.
Abstract:
The immunoprotective beta-mannan of Candida albicans occurs as part of the cell wall phosphomannan N-linked glycoprotein. This macromolecule is composed of an extended alpha1,6 linked mannopyranan backbone containing alpha1,2 mannopyranan branches, to which beta1,2 mannopyranan epitopes are attached. The synthesis of beta1,2-mannan disaccharides clustered on a glucose core has been achieved as a way to imitate the multipoint display of beta-mannans in the native glycoprotein. The clustered epitopes were conjugated to tetanus toxoid and bovine serum albumin. Rabbits immunized with tetanus toxoid cluster glycoconjugate gave good antibody titres for the disaccharide cluster or simple trisaccharide epitope (coupled to BSA). The anti-sera also showed strong cross-reactivity with a Candida albicansbeta-mannan cell wall extract. These immunochemical results are compared with data obtained with non-cluster disaccharide and trisaccharide glycoconjugate antigens. The same conjugates gave substantially lower antibody levels when used to immunize mice.

